10 hrs ago | Health
New Drug Fights Hard-to-Treat Psoriasis
After she was diagnosed with psoriasis in 1992, at the age of 17, Sherrina Navani tried just about a oeeverything and anythinga -natural remedies, topical treatments, prescription drugs such as methotrexate-to heal the cracking, bleeding plaques that covered 90% of her body.
Actelion to pursue development of S1P1
Actelion Ltd., /quotes/comstock/11i!aliof /quotes/comstock/06p!atln-otc the Allshwil, Switzerland, drugmaker, said on Tuesday that it would proceed with advanced clinical development for S1P1 as a treatment for psoriasis.
Researchers identify immune cells that trigger psoriasis
Researchers have discovered a novel type of immune cell in the skin of individuals with chronic skin inflammations which could lead to long-lasting therapies against asthma, COPD, psoriasis, as well as assist healing.
Pine! - The Scent of The Holiday Season
It's beginning to smell a lot like .... Christmas! Not that pine is used only at Christmas time but this is the time of year that we give it our undivided attention.
Provectus Announces Preliminary Phase 2 Data For PH-10 in its Psoriasis and Atopic Dermatitis Trials
Dec 1, 2009 - Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
There is a message circulating on the Web about putting an unpeeled onion in a room to attract flu viruses.
International Psoriasis Council Hosts Second Educational Symposium to ...
Beginning Thursday, Nov. 19, 2009, the International Psoriasis Council will host its second symposium at Baylor University Medical Center in Dallas.
Health Scan: Psoriasis causes both physical and social suffering
Although psoriasis - the skin disease that causes itchy red and scaly skin patches in some 200,000 Israelis - is not infectious, a third of the population don't want to wok with a sufferer of the condition, according to a new survey conducted for Tel Aviv Sourasky Medical Center.
Stelara, first IL inhibitor, expected to change dermatologistsa ...
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Centocor Ortho Biotech's Stelara, the first interleukin -12/23 inhibitor to enter the psoriasis drug market in the U.S., is expected to change the prescribing habits of dermatologists and substantially alter ...
Biocon hums with plans, pitches for global top 3 slot
Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical players across the globe, said Kiran Mazumdar-Shaw, chairman and managing director.
Psoriatic Arthritis Common in People With Psoriasis
As many as 14 percent of people with psoriasis may also have psoriatic arthritis, research shows.
Women-XtraEdition - Indiatimes
Turmeric can treat psoriasis, Alzheimer's
Curcumin, an ingredient commonly found in yellow curry, is being viewed as a promising disease-fighter . Scientists are working on developing nano-sized capsules containing the curry ingredient in an effort to improve its absorption and effectiveness in the body.
Press Release News From 24-7 Press Re...
Mushatts Donates To National Psoriasis Foundation Research Programs
Mushatt's LLC today announced that it will donate 2% of its sales revenue to support the National Psoriasis Foundation Research Program.
Study says minorities suffer more from psoriasis
Data from a comprehensive survey of nearly 5,000 people with psoriasis and psoriatic arthritis reveal that African Americans, Asians and Latinos are more likely than Caucasians to suffer psychological effects from the diseases.
Daily News: FDA Approves New Drug to Treat Psoriasis
The U.S. Food and Drug Administration approved Stelara , a biologic product for adults who have a moderate to severe form of psoriasis.
Website becomes virtual resource for Canadians living with psoriasis
With an online community of more than 2,500 people, Psoriasis Support Canada has become a vital resource for Canadians impacted by psoriasis.
Psoriasis is a chronic, non-contagious auto-immune disease that affects the skin and joints.
Important correction for psoriasis treatment
DEAR DR. GOTT: I recently wrote you regarding my experience with psoriasis, for which my husband recommended that I take fish oil and vitamin D3.
TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, ...
Back in the dim days of black-and-white television, one over-the-counter product that was frequently advertised claimed to help "the heartbreak of psoriasis." The phrase is no longer heard in commercials, but the heartbreak is still there.
Also on Topix